Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis

Oncogene

Volumn 35, Issue 18, 2016, Pages 2390-2397

  Nagaraja, A S ^a   Dorniak, P L ^a   Sadaoui, N C ^a   Kang, Y ^a   Lin, T ^a   Armaiz Pena, G ^a   Wu, S Y ^a   Rupaimoole, R ^a   Allen, J K ^a   Gharpure, K M ^a   Pradeep, S ^a   Zand, B ^a   Previs, R A ^a   Hansen, J M ^a   Ivan, C ^a   Rodriguez Aguayo, C ^a   Yang, P ^a   Lopez Berestein, G ^a   Lutgendorf, S K ^b   Cole, S W ^c   Sood, A K ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRB2 PROTEIN; BETA ADRENERGIC RECEPTOR; BUTOXAMINE; CATECHOLAMINE; HYDROCORTISONE; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPRENALINE; NORADRENALIN; PROPRANOLOL; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; PROTEIN; PTGES PROTEIN; PTGS2 PROTEIN; SMALL INTERFERING RNA; TERBUTALINE; UNCLASSIFIED DRUG; CYCLOOXYGENASE 2; PROSTAGLANDIN E SYNTHASE; PTGES PROTEIN, HUMAN;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MIGRATION; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHROMATIN IMMUNOPRECIPITATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMOBILIZATION STRESS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MASS SPECTROMETRY; METASTASIS; MOUSE; NONHUMAN; OVARIAN CANCER CELL LINE; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; ANIMAL; BIOSYNTHESIS; DEFICIENCY; GENE SILENCING; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GENE SILENCING; HUMANS; MICE; NEOPLASM METASTASIS; NOREPINEPHRINE; OVARIAN NEOPLASMS; PROSTAGLANDIN-E SYNTHASES; SIGNAL TRANSDUCTION;

EID: 84938886946     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.302     Document Type: Article

References (30)

1. Costanzo ES, Lutgendorf SK, Sood AK, Anderson B, Sorosky J, Lubaroff DM. Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 2005; 104: 305-313.
2. Hassan S, Karpova Y, Baiz D, Yancey D, Pullikuth A, Flores A et al. Behavioral stress accelerates prostate cancer development in mice. J Clin Invest 2013; 123: 874-886.
3. Kruk J, Aboul-Enein HY. Psychological stress and the risk of breast cancer: a case-control study. Cancer Detect Prev 2004; 28: 399-408.
4. Lutgendorf SK, DeGeest K, Sung CY, Arevalo JM, Penedo F, Lucci J 3rd et al. Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. Brain Behav Immunity 2009; 23: 176-183.
5. Ramirez AJ, Craig TK, Watson JP, Fentiman IS, North WR, Rubens RD. Stress and relapse of breast cancer. BMJ 1989; 298: 291-293.
6. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006; 12: 939-944.
7. Lutgendorf SK, De Geest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L et al. Social influences on clinical outcomes of patients with ovarian cancer. J Clin Oncol 2012; 30: 2885-2890.
8. Wang HM, Liao ZX, Komaki R, Welsh JW, O'Reilly MS, Chang JY et al. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol 2013; 24: 1312-1319.
9. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 2006; 12: 369-375.
10. Sethi J, Yadav M, Dahiya K, Sood S, Singh V, Bhattacharya SB. Antioxidant effect of Triticum aestivium (wheat grass) in high-fat diet-induced oxidative stress in rabbits. Methods Find Exp Clin Pharmacol 2010; 32: 233-235.
11. Gosain A, Jones SB, Shankar R, Gamelli RL, DiPietro LA. Norepinephrine modulates the inflammatory and proliferative phases of wound healing. J Trauma 2006; 60: 736-743.
12. Sivamani RK, Pullar CE, Manabat-Hidalgo CG, Rocke DM, Carlsen RC, Greenhalgh DG et al. Stress-Mediated Increases in Systemic and Local Epinephrine Impair Skin Wound Healing: Potential New Indication for Beta Blockers. PLoS Med 2009; 6: 105-115.
13. Radloff LS. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Appl Psychol Measur 1977, 1977 1: 385-401.
14. Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O et al. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem/FEBS 1994; 221: 889-897.
15. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 2010; 70: 7042-7052.
16. Shakhar G, Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol 1998; 160: 3251-3258.
17. Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 2008; 15: 2042-2052.
18. Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI et al. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immunity 2009; 23: 267-275.
19. Lutgendorf SK, DeGeest K, Dahmoush L, Farley D, Penedo F, Bender D et al. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immunity 2011; 25: 250-255.
20. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 2003; 100: 1920-1925.
21. Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer 2010; 10: 181-193.
22. Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol 2012; 188: 21-28.
23. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009; 30: 377-386.
24. Lin Y, Cui M, Xu T, Yu W, Zhang L. Silencing of cyclooxygenase-2 inhibits the growth, invasion and migration of ovarian cancer cells. Mol Med Rep 2014; 9: 2499-2504.
25. Qiu X, Cheng JC, Chang HM, Leung PC. COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion. Endocr Relat Cancer 2014; 21: 533-543.
26. Matsumoto Y, Ishiko O, Deguchi M, Nakagawa E, Ogita S. Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms. Inter J Mol Med 2001; 8: 31-36.
27. Athanassiadou P, Grapsa D, Athanassiades P, Gonidi M, Athanassiadou AM, Tsipis A et al. The prognostic significance of COX-2 and survivin expression in ovarian cancer. Pathol Res Pract 2008; 204: 241-249.
28. Denkert C, Kobel M, Pest S, Koch I, Berger S, Schwabe M et al. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol 2002; 160: 893-903.
29. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 2009; 81: 6656-6667.
30. Weiner J 3rd, Parida SK, Maertzdorf J, Black GF, Repsilber D, Telaar A et al. Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PLoS ONE 2012; 7: e40221.